// App-Quantinova.ai

87 : Janus kinase inhibitors demonstrate effectiveness in a real-world multi-biologic DMARD refractory rheumatoid arthritis population

Researchers

Presenter

  • John Fitton

Principal Investigators

  • Shouvik Dass

  • Paul Emery

  • Jacqueline Nam

  • Maya H Buch

Medical Centers

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UNITED KINGDOM

  • NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, LEEDS, UK

  • Respiratory, Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Janus kinase

Drug/Treatment

  • Baricitinib

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved